Quick Answer
Sight Sciences, Inc. reported Research And Development Expense of $14.61 million for the year ending 2025.
- Sight Sciences, Inc. showed a decrease of -18.8% in Research And Development Expense from 2024 to 2025.
- This data is from Sight Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $1.44 million | Q3 2020: $2.16 million | Q1 2021: $3.44 million | Q2 2021: $3.55 million | Q3 2021: $4.28 million | Q1 2022: $5.65 million | Q2 2022: $5.93 million | Q3 2022: $6.05 million | Q1 2023: $4.67 million | Q2 2023: $5.22 million | Q3 2023: $4.24 million | Q1 2024: $4.64 million | Q2 2024: $4.32 million | Q3 2024: $4.75 million | Q1 2025: $4.43 million | Q2 2025: $4.39 million | Q3 2025: $3.35 million.
- Over the full 6 years of available data (2020 to 2025), Sight Sciences, Inc.'s Research And Development Expense has grown by 64.6%.
- Historical annual values: Fiscal year 2025: $14.61 million | Fiscal year 2024: $17.99 million | Fiscal year 2023: $17.56 million | Fiscal year 2022: $22.86 million | Fiscal year 2021: $15.63 million | Fiscal year 2020: $8.87 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: